Cargando…

Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study

BACKGROUND: Tissue Doppler imaging (TDI) is a noninvasive echocardiographic method for the diagnosis of diastolic dysfunction in patients with varying degrees of aortic stenosis (AS). Little is known however, on the utility of TDI in the serial assessment of diastolic abnormalities in AS. OBJECTIVE:...

Descripción completa

Detalles Bibliográficos
Autores principales: Jassal, Davinder S, Bhagirath, Kapil M, Karlstedt, Erin, Zeglinski, Matthew, Dumesnil, Jean G, Teo, Koon K, Tam, James W, Chan, Kwan L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041733/
https://www.ncbi.nlm.nih.gov/pubmed/21299902
http://dx.doi.org/10.1186/1476-7120-9-5
_version_ 1782198468615340032
author Jassal, Davinder S
Bhagirath, Kapil M
Karlstedt, Erin
Zeglinski, Matthew
Dumesnil, Jean G
Teo, Koon K
Tam, James W
Chan, Kwan L
author_facet Jassal, Davinder S
Bhagirath, Kapil M
Karlstedt, Erin
Zeglinski, Matthew
Dumesnil, Jean G
Teo, Koon K
Tam, James W
Chan, Kwan L
author_sort Jassal, Davinder S
collection PubMed
description BACKGROUND: Tissue Doppler imaging (TDI) is a noninvasive echocardiographic method for the diagnosis of diastolic dysfunction in patients with varying degrees of aortic stenosis (AS). Little is known however, on the utility of TDI in the serial assessment of diastolic abnormalities in AS. OBJECTIVE: The aim of the current proposal was to examine whether treatment with rosuvastatin was successful in improving diastolic abnormalities in patients enrolled in the Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin (ASTRONOMER) study. METHODS: Conventional Doppler indices including peak early (E) and late (A) transmitral velocities, and E/A ratio were measured from spectral Doppler. Tissue Doppler measurements including early (E') and late (A') velocities of the lateral annulus were determined, and E/E' was calculated. RESULTS: The study population included 168 patients (56 ± 13 years), whose AS severity was categorized based on peak velocity at baseline (Group I: 2.5-3.0 m/s; Group II: 3.1-3.5 m/s; Group III: 3.6-4.0 m/s). Baseline and follow-up hemodynamics, LV dimensions and diastolic functional parameters were evaluated in all three groups. There was increased diastolic dysfunction from baseline to follow-up in each of the placebo and rosuvastatin groups. In patients with increasing severity of AS in Groups I and II, the lateral E' was lower and the E/E' (as an estimate of increased left ventricular end-diastolic pressure) was higher at baseline (p < 0.05). However, treatment with rosuvastatin did not affect the progression of diastolic dysfunction from baseline to 3.5 year follow-up between patients in any of the three predefined groups. CONCLUSION: In patients with mild to moderate asymptomatic AS, rosuvastatin did not attenuate the progression of diastolic dysfunction.
format Text
id pubmed-3041733
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30417332011-02-19 Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study Jassal, Davinder S Bhagirath, Kapil M Karlstedt, Erin Zeglinski, Matthew Dumesnil, Jean G Teo, Koon K Tam, James W Chan, Kwan L Cardiovasc Ultrasound Research BACKGROUND: Tissue Doppler imaging (TDI) is a noninvasive echocardiographic method for the diagnosis of diastolic dysfunction in patients with varying degrees of aortic stenosis (AS). Little is known however, on the utility of TDI in the serial assessment of diastolic abnormalities in AS. OBJECTIVE: The aim of the current proposal was to examine whether treatment with rosuvastatin was successful in improving diastolic abnormalities in patients enrolled in the Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin (ASTRONOMER) study. METHODS: Conventional Doppler indices including peak early (E) and late (A) transmitral velocities, and E/A ratio were measured from spectral Doppler. Tissue Doppler measurements including early (E') and late (A') velocities of the lateral annulus were determined, and E/E' was calculated. RESULTS: The study population included 168 patients (56 ± 13 years), whose AS severity was categorized based on peak velocity at baseline (Group I: 2.5-3.0 m/s; Group II: 3.1-3.5 m/s; Group III: 3.6-4.0 m/s). Baseline and follow-up hemodynamics, LV dimensions and diastolic functional parameters were evaluated in all three groups. There was increased diastolic dysfunction from baseline to follow-up in each of the placebo and rosuvastatin groups. In patients with increasing severity of AS in Groups I and II, the lateral E' was lower and the E/E' (as an estimate of increased left ventricular end-diastolic pressure) was higher at baseline (p < 0.05). However, treatment with rosuvastatin did not affect the progression of diastolic dysfunction from baseline to 3.5 year follow-up between patients in any of the three predefined groups. CONCLUSION: In patients with mild to moderate asymptomatic AS, rosuvastatin did not attenuate the progression of diastolic dysfunction. BioMed Central 2011-02-07 /pmc/articles/PMC3041733/ /pubmed/21299902 http://dx.doi.org/10.1186/1476-7120-9-5 Text en Copyright ©2011 Jassal et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Jassal, Davinder S
Bhagirath, Kapil M
Karlstedt, Erin
Zeglinski, Matthew
Dumesnil, Jean G
Teo, Koon K
Tam, James W
Chan, Kwan L
Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study
title Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study
title_full Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study
title_fullStr Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study
title_full_unstemmed Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study
title_short Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study
title_sort evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (astronomer) study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041733/
https://www.ncbi.nlm.nih.gov/pubmed/21299902
http://dx.doi.org/10.1186/1476-7120-9-5
work_keys_str_mv AT jassaldavinders evaluatingtheeffectivenessofrosuvastatininpreventingtheprogressionofdiastolicdysfunctioninaorticstenosisasubstudyoftheaorticstenosisprogressionobservationmeasuringeffectsofrosuvastatinastronomerstudy
AT bhagirathkapilm evaluatingtheeffectivenessofrosuvastatininpreventingtheprogressionofdiastolicdysfunctioninaorticstenosisasubstudyoftheaorticstenosisprogressionobservationmeasuringeffectsofrosuvastatinastronomerstudy
AT karlstedterin evaluatingtheeffectivenessofrosuvastatininpreventingtheprogressionofdiastolicdysfunctioninaorticstenosisasubstudyoftheaorticstenosisprogressionobservationmeasuringeffectsofrosuvastatinastronomerstudy
AT zeglinskimatthew evaluatingtheeffectivenessofrosuvastatininpreventingtheprogressionofdiastolicdysfunctioninaorticstenosisasubstudyoftheaorticstenosisprogressionobservationmeasuringeffectsofrosuvastatinastronomerstudy
AT dumesniljeang evaluatingtheeffectivenessofrosuvastatininpreventingtheprogressionofdiastolicdysfunctioninaorticstenosisasubstudyoftheaorticstenosisprogressionobservationmeasuringeffectsofrosuvastatinastronomerstudy
AT teokoonk evaluatingtheeffectivenessofrosuvastatininpreventingtheprogressionofdiastolicdysfunctioninaorticstenosisasubstudyoftheaorticstenosisprogressionobservationmeasuringeffectsofrosuvastatinastronomerstudy
AT tamjamesw evaluatingtheeffectivenessofrosuvastatininpreventingtheprogressionofdiastolicdysfunctioninaorticstenosisasubstudyoftheaorticstenosisprogressionobservationmeasuringeffectsofrosuvastatinastronomerstudy
AT chankwanl evaluatingtheeffectivenessofrosuvastatininpreventingtheprogressionofdiastolicdysfunctioninaorticstenosisasubstudyoftheaorticstenosisprogressionobservationmeasuringeffectsofrosuvastatinastronomerstudy